Asia Medical Agricultural Stock Current Asset
AMARC Stock | 1.38 0.04 2.82% |
Asia Medical Agricultural fundamentals help investors to digest information that contributes to Asia Medical's financial success or failures. It also enables traders to predict the movement of Asia Stock. The fundamental analysis module provides a way to measure Asia Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Asia Medical stock.
Asia |
Asia Medical Agricultural Company Current Asset Analysis
Asia Medical's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition |
In accordance with the recently published financial statements, Asia Medical Agricultural has a Current Asset of 0.0. This is 100.0% lower than that of the Technology sector and 100.0% lower than that of the Scientific & Technical Instruments industry. The current asset for all Thailand stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
All Next | Launch Module |
Asia Fundamentals
Profit Margin | 0.1 % | |||
Operating Margin | 0.14 % | |||
Current Valuation | 1.47 B | |||
Shares Outstanding | 420 M | |||
Shares Owned By Insiders | 73.64 % | |||
Price To Book | 5.93 X | |||
Price To Sales | 4.48 X | |||
Revenue | 271.77 M | |||
Gross Profit | 109.51 M | |||
EBITDA | 62.16 M | |||
Book Value Per Share | 0.71 X | |||
Earnings Per Share | 0.08 X | |||
Number Of Employees | 221 | |||
Market Capitalization | 1.23 B | |||
Last Dividend Paid | 0.05 |
About Asia Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Asia Medical Agricultural's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Asia Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Asia Medical Agricultural based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Asia Stock
Asia Medical financial ratios help investors to determine whether Asia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Asia with respect to the benefits of owning Asia Medical security.